Intra-Cellular Therapies, Inc.

MORGAN STANLEY

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/15/2025

Shares

1,403,399

Value ($000)

185,137

Weight

0.0%

2014 Q1 - 2025 Q1 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/15/2025	185,137	0.0%	1,403,399	3/31/2025
2024 Q4	5/15/2025	74,532	0.0%	892,386	12/31/2024
2024 Q3	5/14/2025	61,186	0.0%	836,210	9/30/2024
2024 Q2	5/14/2025	70,536	0.0%	1,029,869	6/30/2024
2024 Q1	5/15/2024	65,034	0.0%	939,797	3/31/2024
2023 Q4	2/13/2024	88,954	0.0%	1,242,020	12/31/2023
2023 Q3	11/15/2023	48,735	0.0%	935,587	9/30/2023
2023 Q2	8/14/2023	65,057	0.0%	1,027,425	6/30/2023
2023 Q1	5/15/2023	38,643	0.0%	713,625	3/31/2023
2022 Q4	2/14/2023	50,815	0.0%	960,218	12/31/2022
2022 Q3	11/14/2022	40,503	0.0%	870,460	9/30/2022
2022 Q2	10/27/2022	44,380	0.0%	777,537	6/30/2022
2022 Q1	10/27/2022	40,016	0.0%	653,984	3/31/2022
2021 Q4	2/14/2022	36,371	0.0%	694,898	12/31/2021
2021 Q3	11/15/2021	27,515	0.0%	738,020	9/30/2021
2021 Q2	8/23/2021	27,074	0.0%	663,263	6/30/2021
2021 Q1	5/17/2021	14,863	0.0%	438,061	3/31/2021
2020 Q4	2/16/2021	15,275	0.0%	480,343	12/31/2020
2020 Q3	11/13/2020	13,021	0.0%	507,421	9/30/2020
2020 Q2	8/14/2020	13,046	0.0%	508,191	6/30/2020
2020 Q1	5/26/2020	8,320	0.0%	541,290	3/31/2020
2019 Q4	2/14/2020	31,106	0.0%	906,611	12/31/2019
2014 Q1	5/13/2014	2,230	0.0%	122,688	3/31/2014